(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of YAP1 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:1550378 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of YAP1 mRNA CTD PMID:36331819 (20S)-ginsenoside Rg3 decreases expression ISO RGD:1314421 6480464 ginsenoside Rg3 results in decreased expression of YAP1 mRNA CTD PMID:31916386 1,2-dimethylhydrazine increases expression ISO RGD:1550378 6480464 1, 2-Dimethylhydrazine results in increased expression of YAP1 mRNA CTD PMID:22206623 17beta-estradiol affects expression ISO RGD:1314421 6480464 Estradiol affects the expression of YAP1 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1314421 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of YAP1 mRNA more ... CTD PMID:19684285 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of YAP1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550378 6480464 Tetrachlorodibenzodioxin results in decreased expression of YAP1 mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine affects response to substance ISO RGD:1314421 6480464 YAP1 affects the susceptibility to Tetrachlorodibenzodioxin CTD PMID:31536130 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1314421 6480464 Tetrachlorodibenzodioxin results in increased expression of YAP1 mRNA CTD PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550378 6480464 Tetrachlorodibenzodioxin affects the expression of YAP1 mRNA CTD PMID:21570461 , PMID:36222588 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1314421 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YAP1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1314421 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of YAP1 protein CTD PMID:34186270 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of YAP1 mRNA CTD PMID:31881176 aconitine increases expression EXP 6480464 Aconitine results in increased expression of YAP1 protein CTD PMID:33236894 acrolein multiple interactions ISO RGD:1314421 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of YAP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of YAP1 mRNA CTD PMID:32699268 aflatoxin B1 increases expression ISO RGD:1314421 6480464 Aflatoxin B1 results in increased expression of YAP1 mRNA CTD PMID:22100608 alpha-pinene multiple interactions ISO RGD:1314421 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of YAP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of YAP1 mRNA CTD PMID:32699268 antirheumatic drug increases expression ISO RGD:1314421 6480464 Antirheumatic Agents results in increased expression of YAP1 mRNA CTD PMID:24449571 arsane affects localization ISO RGD:1550378 6480464 Arsenic affects the localization of YAP1 protein CTD PMID:23942117 arsane affects localization ISO RGD:1314421 6480464 Arsenic affects the localization of YAP1 protein CTD PMID:28524356 arsane multiple interactions ISO RGD:1550378 6480464 Arsenic results in increased expression of and results in decreased phosphorylation of YAP1 protein CTD PMID:23942117 arsenic atom multiple interactions ISO RGD:1550378 6480464 Arsenic results in increased expression of and results in decreased phosphorylation of YAP1 protein CTD PMID:23942117 arsenic atom affects localization ISO RGD:1314421 6480464 Arsenic affects the localization of YAP1 protein CTD PMID:28524356 arsenic atom affects localization ISO RGD:1550378 6480464 Arsenic affects the localization of YAP1 protein CTD PMID:23942117 arsenite(3-) multiple interactions ISO RGD:1314421 6480464 arsenite inhibits the reaction [G3BP1 protein binds to YAP1 mRNA] CTD PMID:32406909 belinostat multiple interactions ISO RGD:1314421 6480464 belinostat results in decreased expression of and results in decreased phosphorylation of YAP1 protein CTD PMID:23671600 benzo[a]pyrene decreases expression ISO RGD:1314421 6480464 Benzo(a)pyrene results in decreased expression of YAP1 mRNA CTD PMID:20106945 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1314421 6480464 7 more ... CTD PMID:19150397 bisphenol A increases expression ISO RGD:1550378 6480464 bisphenol A results in increased expression of YAP1 mRNA CTD PMID:26063408 bisphenol A multiple interactions ISO RGD:1550378 6480464 Imatinib Mesylate inhibits the reaction [bisphenol A results in increased phosphorylation of YAP1 protein] CTD PMID:35219798 bisphenol A increases phosphorylation ISO RGD:1550378 6480464 bisphenol A results in increased phosphorylation of YAP1 protein CTD PMID:35219798 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of YAP1 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of YAP1 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol F multiple interactions ISO RGD:1314421 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YAP1 mRNA CTD PMID:28628672 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of YAP1 protein CTD PMID:28903499 caffeine affects phosphorylation ISO RGD:1314421 6480464 Caffeine affects the phosphorylation of YAP1 protein CTD PMID:35688186 captan decreases expression ISO RGD:1550378 6480464 Captan results in decreased expression of YAP1 mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:1314421 6480464 Carbamazepine affects the expression of YAP1 mRNA CTD PMID:25979313 chlorpromazine multiple interactions ISO RGD:1314421 6480464 Chlorpromazine results in decreased expression of and results in increased phosphorylation of and affects the localization of YAP1 protein CTD PMID:30703373 choline multiple interactions ISO RGD:1550378 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of YAP1 gene CTD PMID:20938992 chrysene increases expression ISO RGD:1550378 6480464 chrysene results in increased expression of YAP1 mRNA CTD PMID:26377693 cisplatin increases expression ISO RGD:1314421 6480464 Cisplatin results in increased expression of YAP1 protein modified form CTD PMID:21214929 cisplatin multiple interactions ISO RGD:1550378 6480464 Imatinib Mesylate inhibits the reaction [Cisplatin results in increased phosphorylation of YAP1 protein] CTD PMID:35219798 cisplatin increases phosphorylation ISO RGD:1550378 6480464 Cisplatin results in increased phosphorylation of YAP1 protein CTD PMID:35219798 cisplatin decreases response to substance ISO RGD:1314421 6480464 YAP1 results in decreased susceptibility to Cisplatin CTD PMID:20947521 cisplatin increases response to substance ISO RGD:1314421 6480464 YAP1 protein results in increased susceptibility to Cisplatin CTD PMID:20729916 cisplatin multiple interactions ISO RGD:1314421 6480464 [Cisplatin co-treated with 2 more ... CTD PMID:20947521 more ... copper(II) sulfate increases expression ISO RGD:1314421 6480464 Copper Sulfate results in increased expression of YAP1 mRNA CTD PMID:19549813 coumarin affects phosphorylation ISO RGD:1314421 6480464 coumarin affects the phosphorylation of YAP1 protein CTD PMID:35688186 crocidolite asbestos increases expression ISO RGD:1314421 6480464 Asbestos, Crocidolite results in increased expression of YAP1 mRNA CTD PMID:18687144 Cuprizon affects expression EXP 6480464 Cuprizone affects the expression of YAP1 mRNA CTD PMID:27523638 cycloheximide multiple interactions ISO RGD:1314421 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of YAP1 mRNA CTD PMID:19684285 deoxynivalenol decreases phosphorylation ISO RGD:1314421 6480464 deoxynivalenol results in decreased phosphorylation of YAP1 protein CTD PMID:33890134 dexamethasone multiple interactions ISO RGD:1314421 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YAP1 mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO RGD:1550378 6480464 [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased phosphorylation of and affects the localization of YAP1 protein CTD PMID:24146755 dibutyl phthalate decreases expression ISO RGD:1550378 6480464 Dibutyl Phthalate results in decreased expression of YAP1 mRNA CTD PMID:17361019 dichloroacetic acid affects localization ISO RGD:1314421 6480464 Dichloroacetic Acid affects the localization of YAP1 protein CTD PMID:33405312 dichloroacetic acid multiple interactions ISO RGD:1314421 6480464 YAP1 protein mutant form inhibits the reaction [Dichloroacetic Acid results in decreased expression of EPCAM mRNA] more ... CTD PMID:33405312 dioxygen multiple interactions ISO RGD:1550378 6480464 [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of YAP1 mRNA more ... CTD PMID:35307376 dorsomorphin multiple interactions ISO RGD:1314421 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1314421 6480464 Doxorubicin results in increased expression of YAP1 protein modified form CTD PMID:21214929 doxorubicin increases phosphorylation EXP 6480464 Doxorubicin results in increased phosphorylation of YAP1 protein CTD PMID:35093381 doxorubicin decreases expression ISO RGD:1314421 6480464 Doxorubicin results in decreased expression of YAP1 mRNA CTD PMID:29803840 doxorubicin decreases response to substance EXP 6480464 YAP1 protein results in decreased susceptibility to Doxorubicin CTD PMID:32434049 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of YAP1 mRNA, Doxorubicin results in decreased expression of YAP1 protein CTD PMID:32434049 doxorubicin multiple interactions EXP 6480464 Doxorubicin inhibits the reaction [YAP1 protein binds to PRKN promoter] more ... CTD PMID:32434049 , PMID:35093381 doxorubicin multiple interactions ISO RGD:1314421 6480464 [Doxorubicin co-treated with 2 more ... CTD PMID:21214929 ethanol increases expression ISO RGD:1550378 6480464 Ethanol results in increased expression of YAP1 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1314421 6480464 Ethyl Methanesulfonate results in increased expression of YAP1 mRNA CTD PMID:23649840 fipronil increases expression EXP 6480464 fipronil results in increased expression of YAP1 mRNA CTD PMID:34044035 fisetin multiple interactions ISO RGD:1314421 6480464 fisetin results in increased phosphorylation of and affects the localization of YAP1 protein CTD PMID:31044527 folic acid multiple interactions ISO RGD:1550378 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of YAP1 gene CTD PMID:20938992 fonofos increases methylation ISO RGD:1314421 6480464 Fonofos results in increased methylation of YAP1 promoter CTD PMID:22847954 formaldehyde increases expression ISO RGD:1314421 6480464 Formaldehyde results in increased expression of YAP1 mRNA CTD PMID:23649840 fulvestrant increases methylation ISO RGD:1314421 6480464 Fulvestrant results in increased methylation of YAP1 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of YAP1 protein CTD PMID:27371368 gemcitabine affects response to substance ISO RGD:1314421 6480464 YAP1 protein affects the susceptibility to Gemcitabine CTD PMID:26894857 gemcitabine multiple interactions ISO RGD:1314421 6480464 SFN protein affects the reaction [YAP1 protein promotes the reaction [SFN protein results in decreased susceptibility to Gemcitabine]] more ... CTD PMID:26894857 gingerol multiple interactions ISO RGD:1314421 6480464 [gingerol co-treated with YAP1 protein] results in increased phosphorylation of YAP1 protein more ... CTD PMID:32926756 gingerol affects localization ISO RGD:1314421 6480464 gingerol affects the localization of YAP1 protein CTD PMID:32926756 glyphosate increases methylation EXP 6480464 glyphosate results in increased methylation of YAP1 gene CTD PMID:31011160 indometacin multiple interactions ISO RGD:1314421 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YAP1 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:1314421 6480464 Ivermectin results in decreased expression of YAP1 protein CTD PMID:32959892 jaspamide multiple interactions ISO RGD:1314421 6480464 jasplakinolide results in decreased phosphorylation of and affects the localization of YAP1 protein more ... CTD PMID:24040060 L-methionine multiple interactions ISO RGD:1550378 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of YAP1 gene CTD PMID:20938992 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of YAP1 mRNA CTD PMID:21864555 Licochalcone A decreases expression ISO RGD:1314421 6480464 licochalcone A results in decreased expression of YAP1 mRNA, licochalcone A results in decreased expression of YAP1 protein CTD PMID:34845814 Licochalcone A multiple interactions ISO RGD:1314421 6480464 XMU-MP-1 inhibits the reaction [licochalcone A results in increased expression of YAP1 protein modified form] CTD PMID:34845814 limonin affects localization ISO RGD:1314421 6480464 limonin affects the localization of YAP1 protein CTD PMID:30738134 MeIQx decreases expression ISO RGD:1314421 6480464 2-amino-3 more ... CTD PMID:20816883 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Doxorubicin results in increased phosphorylation of YAP1 protein] more ... CTD PMID:35093381 methylmercury chloride increases expression ISO RGD:1314421 6480464 methylmercuric chloride results in increased expression of YAP1 mRNA CTD PMID:28001369 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1314421 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 mRNA CTD PMID:31351048 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1314421 6480464 IRF1 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 mRNA] more ... CTD PMID:31351048 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1314421 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [tcdA protein more ... CTD PMID:33251692 N-nitrosodiethylamine multiple interactions ISO RGD:1550378 6480464 [1 more ... CTD PMID:21391223 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of YAP1 protein CTD PMID:31369848 octreotide multiple interactions ISO RGD:1550378 6480464 Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of YAP1 mRNA] more ... CTD PMID:35307376 ozone multiple interactions ISO RGD:1314421 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of YAP1 mRNA more ... CTD PMID:32699268 panobinostat increases expression ISO RGD:1314421 6480464 panobinostat results in increased expression of YAP1 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1314421 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA CTD PMID:27188386 paracetamol decreases expression ISO RGD:1314421 6480464 Acetaminophen results in decreased expression of YAP1 mRNA CTD PMID:21420995 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of YAP1 mRNA CTD PMID:33387578 paracetamol decreases response to substance ISO RGD:1550378 6480464 YAP1 gene mutant form results in decreased susceptibility to Acetaminophen CTD PMID:34546377 paracetamol multiple interactions ISO RGD:1550378 6480464 Acetaminophen results in increased expression of and affects the localization of YAP1 protein more ... CTD PMID:34546377 paraoxon decreases expression ISO RGD:1314421 6480464 Paraoxon results in decreased expression of YAP1 mRNA CTD PMID:24413757 parathion increases methylation ISO RGD:1314421 6480464 Parathion results in increased methylation of YAP1 promoter CTD PMID:22847954 pentachlorophenol increases expression ISO RGD:1550378 6480464 Pentachlorophenol results in increased expression of YAP1 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1550378 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of YAP1 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of YAP1 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:1550378 6480464 perfluorooctanoic acid results in increased expression of YAP1 mRNA CTD PMID:36152675 perfluorooctanoic acid multiple interactions ISO RGD:1314421 6480464 perfluorooctanoic acid results in increased expression of and results in decreased phosphorylation of YAP1 protein CTD PMID:35346789 phenylmercury acetate increases expression ISO RGD:1314421 6480464 Phenylmercuric Acetate results in increased expression of YAP1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1314421 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA CTD PMID:27188386 quartz affects expression ISO RGD:1550378 6480464 Quartz affects the expression of YAP1 protein CTD PMID:36053221 quartz affects localization ISO RGD:1550378 6480464 Quartz affects the localization of YAP1 protein CTD PMID:36053221 quartz multiple interactions ISO RGD:1550378 6480464 CAV1 protein modified form inhibits the reaction [Quartz affects the localization of YAP1 protein], CAV1 protein modified form inhibits the reaction [Quartz results in increased expression of YAP1 protein] CTD PMID:36053221 quercetin decreases expression ISO RGD:1314421 6480464 Quercetin results in decreased expression of YAP1 mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:1314421 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite increases expression ISO RGD:1314421 6480464 sodium arsenite results in increased expression of YAP1 mRNA CTD PMID:28595984 sorafenib decreases response to substance ISO RGD:1314421 6480464 YAP1 protein results in decreased susceptibility to sorafenib CTD PMID:29698666 sunitinib increases expression ISO RGD:1314421 6480464 Sunitinib results in increased expression of YAP1 mRNA CTD PMID:31533062 terbufos increases methylation ISO RGD:1314421 6480464 terbufos results in increased methylation of YAP1 promoter CTD PMID:22847954 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of YAP1 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1550378 6480464 Carbon Tetrachloride results in increased expression of YAP1 mRNA, Carbon Tetrachloride results in increased expression of YAP1 protein CTD PMID:31919559 , PMID:32996673 tetrachloromethane multiple interactions ISO RGD:1550378 6480464 GANT 61 inhibits the reaction [Carbon Tetrachloride results in increased expression of YAP1 mRNA], GANT 61 inhibits the reaction [Carbon Tetrachloride results in increased expression of YAP1 protein] CTD PMID:32996673 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of YAP1 mRNA] CTD PMID:31150632 theophylline decreases expression ISO RGD:1314421 6480464 Theophylline results in decreased expression of YAP1 mRNA CTD PMID:18951874 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of YAP1 mRNA CTD PMID:34492290 titanium dioxide affects expression ISO RGD:1550378 6480464 titanium dioxide affects the expression of YAP1 mRNA CTD PMID:17656681 trichloroethene decreases expression ISO RGD:1550378 6480464 Trichloroethylene results in decreased expression of YAP1 mRNA CTD PMID:19448997 trichostatin A increases expression ISO RGD:1314421 6480464 trichostatin A results in increased expression of YAP1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1314421 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA CTD PMID:27188386 triptonide decreases expression ISO RGD:1550378 6480464 triptonide results in decreased expression of YAP1 mRNA CTD PMID:33045310 valproic acid decreases expression ISO RGD:1550378 6480464 Valproic Acid results in decreased expression of YAP1 mRNA CTD PMID:20546886 , PMID:21427059 valproic acid multiple interactions ISO RGD:1314421 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1314421 6480464 Valproic Acid results in increased expression of YAP1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1314421 6480464 Valproic Acid affects the expression of YAP1 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1314421 6480464 Valproic Acid results in decreased expression of YAP1 mRNA CTD PMID:29154799 vemurafenib multiple interactions ISO RGD:1314421 6480464 [YAP1 protein mutant form results in decreased susceptibility to vemurafenib] inhibits the reaction [vemurafenib results in decreased expression of MYC protein] more ... CTD PMID:26668268 vemurafenib decreases response to substance ISO RGD:1314421 6480464 YAP1 protein mutant form results in decreased susceptibility to vemurafenib CTD PMID:26668268 vemurafenib affects localization ISO RGD:1314421 6480464 vemurafenib affects the localization of YAP1 protein CTD PMID:26668268 verteporfin multiple interactions ISO RGD:1314421 6480464 Verteporfin inhibits the reaction [AMOTL1 protein results in increased activity of YAP1 protein] more ... CTD PMID:29725256 more ... verteporfin decreases activity ISO RGD:1314421 6480464 Verteporfin results in decreased activity of YAP1 protein CTD PMID:34351699 more ... verteporfin decreases expression EXP 6480464 Verteporfin results in decreased expression of YAP1 protein CTD PMID:35093381 verteporfin multiple interactions EXP 6480464 Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased phosphorylation of YAP1 protein]] CTD PMID:35093381 verteporfin multiple interactions ISO RGD:1550378 6480464 Verteporfin inhibits the reaction [YAP1 protein binds to TEAD1 protein] CTD PMID:29893953 verteporfin decreases expression ISO RGD:1314421 6480464 Verteporfin results in decreased expression of YAP1 protein CTD PMID:31494105 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of YAP1 gene CTD PMID:30207508 vinclozolin decreases expression ISO RGD:1550378 6480464 vinclozolin results in decreased expression of YAP1 mRNA CTD PMID:31601345 , PMID:34182078 vinclozolin multiple interactions ISO RGD:1550378 6480464 vinclozolin results in decreased expression of and results in increased phosphorylation of YAP1 protein CTD PMID:31601345 , PMID:34182078 wortmannin multiple interactions ISO RGD:1314421 6480464 wortmannin promotes the reaction [Cisplatin results in increased expression of YAP1 protein modified form], wortmannin promotes the reaction [Doxorubicin results in increased expression of YAP1 protein modified form] CTD PMID:21214929 zearalenone increases expression ISO RGD:1550378 6480464 Zearalenone results in increased expression of YAP1 mRNA CTD PMID:30138655 zearalenone increases phosphorylation ISO RGD:1550378 6480464 Zearalenone results in increased phosphorylation of YAP1 protein CTD PMID:30138655 zinc atom multiple interactions ISO RGD:1314421 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of YAP1 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1314421 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of YAP1 mRNA CTD PMID:18593933